Alarming headlines about surging Covid-19 cases in some states dominated the news this week, but there was some good news: A University of Oxford drug trial found that a low-cost steroid can substantially reduce deaths in severely ill patients. As results from more studies roll in this summer, improved treatments could blunt the impact of any second wave. The randomized trial compared 2,100 hospitalized patients who received the steroid dexamethasone at low-to-moderate doses for 10 days with 4,300 controls receiving standard...

Source: Wall Street Journal June 19, 2020 22:52 UTC